Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Provention Bio Inc. PRVB

Healthcare Biotechnology
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PRVB)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:PRVB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PRVB)

PRVB. Here we Go

https://en.jobs.sanofi.com/job/bridgewater/brand-manager-teplizumab/20873/39389776208
Passitalong - November 10, 2022

RE:up big time today

TEA.v up 1000% Yes One Thousand Percent Folks Mann.c Lithium Expl is Next to Explode new Lithium explorer in Quebec TEA.v...
VbayNo2 - November 3, 2022

up big time today

This is my top mover today (up over 20%). I'm not really sure why. Anyone have an explanation?
treehill - November 3, 2022

let the fun ride begin .....

<< View Post To Watch Video >>
flyjeetu - May 26, 2021

PRVB - let the fun ride begin ....

https://youtu.be/3i7EiEJiLP0
flyjeetu - May 26, 2021

waiting for FDA approval

Teplizumab - reduces the need for insulin - delay onset of type 1 diabetes looking for approval - potentially represents the...
YoEdwest - March 8, 2021
View more Bullboard ››

Kane Biotech Inc.

Kane Biotech Inc.

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and ...
View More »